Direct-to-Biology workflows move crude reaction mixtures straight into assays, giving hit-to-lead teams earlier data to guide series selection.
Euan Fordyce
Advertisement
Euan Fordyce is associate director of chemistry for Sygnature Discovery.
Articles by Euan Fordyce
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Adalvo Acquires Enzene’s Romiplostim Biosimilar Program for ITP
2
Aclaris’ TSLP/IL-4Rα Bispecific ATI-052 Shows Early Activity in Atopic Dermatitis and Asthma
3
Immatics’ PRAME-Targeted TCR Bispecific IMA402 Shows 32% Response Rate in PRAME-High Tumors
4
The BioPharm Brief: Two Phase 3 ADC Wins and a TCR Bispecific in PRAME-High Tumors
5